TherapeuticsMD, Inc. — Revenue by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2bc26fbf-8a9c-4748-a719-dabcf3bff561/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $3.0M | 2025-01-01 – 2025-12-31 | evidence 0001213900-26-036515 |
| FY 2024 | $1.8M | 2024-01-01 – 2024-12-31 | evidence 0001013762-25-003442 |
| FY 2023 | $1.3M | 2023-01-01 – 2023-12-31 | evidence 0001013762-25-003442 |
| FY 2022 | $70.0M | 2022-01-01 – 2022-12-31 | evidence 0001213900-24-028003 |
| FY 2021 | $2.6M | 2021-01-01 – 2021-12-31 | evidence 0001564590-23-005514 |
| FY 2020 | $64.9M | 2020-01-01 – 2020-12-31 | evidence 0001564590-22-011525 |
| FY 2019 | $49.6M | 2019-01-01 – 2019-12-31 | evidence 0001564590-22-011525 |
| FY 2018 | $16.1M | 2018-01-01 – 2018-12-31 | evidence 0001387131-19-001471 |
| FY 2017 | $16.8M | 2017-01-01 – 2017-12-31 | evidence 0001387131-19-001471 |
| FY 2016 | $19.4M | 2016-01-01 – 2016-12-31 | evidence 0001387131-19-001471 |
| FY 2015 | $20.1M | 2015-01-01 – 2015-12-31 | evidence 0001387131-16-004361 |
| FY 2014 | $15.0M | 2014-01-01 – 2014-12-31 | evidence 0001387131-15-000875 |
| FY 2013 | $8.8M | 2013-01-01 – 2013-12-31 | evidence 0001387131-14-000771 |
| FY 2012 | $3.8M | 2012-01-01 – 2012-12-31 | evidence 0001387131-13-000737 |
| FY 2011 | $2.1M | 2011-01-01 – 2011-12-31 | evidence 0001387131-12-000862 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TherapeuticsMD, Inc. — all facts · Net Income · Operating Income